**Core Concept**
Vitamin K-dependent bleeding manifestations in neonates are often caused by maternal use of medications that interfere with vitamin K metabolism or function. This can lead to decreased levels of vitamin K-dependent clotting factors in the neonate, resulting in bleeding complications.

**Why the Correct Answer is Right**
Vitamin K is essential for the gamma-carboxylation of clotting factors II, VII, IX, and X, which are necessary for normal blood coagulation. Certain medications can inhibit the production of vitamin K or interfere with its metabolism, leading to decreased levels of these clotting factors in the neonate.

**Why Each Wrong Option is Incorrect**
* **Option A:** Warfarin is a vitamin K antagonist that can cross the placenta and inhibit vitamin K-dependent clotting factor synthesis, leading to bleeding manifestations in the neonate. It is a well-known cause of vitamin K-dependent bleeding in neonates.
* **Option B:** Phenindione is another vitamin K antagonist that can be used as an anticoagulant. Like warfarin, it can cross the placenta and decrease the levels of vitamin K-dependent clotting factors in the neonate, leading to bleeding complications.
* **Option D:** Phenprocoumon is a vitamin K antagonist that is used as an anticoagulant. It can also cross the placenta and decrease the levels of vitamin K-dependent clotting factors in the neonate, leading to bleeding manifestations.

**Clinical Pearl / High-Yield Fact**
Warfarin, phenindione, and phenprocoumon are all vitamin K antagonists that can cross the placenta and decrease the levels of vitamin K-dependent clotting factors in the neonate, leading to bleeding complications. It is essential for pregnant women to inform their healthcare providers about any medications they are taking, especially anticoagulants, to prevent harm to the fetus.

**Correct Answer: A. Warfarin**